Hepatitis C (HCV) Agents.
[No authors listed]
2022 Feb 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Triple Threat: HDV, HBV, HIV Coinfection.
Yen DW, Soriano V, Barreiro P, Sherman KE.
Clin Liver Dis. 2023 Nov;27(4):955-972. doi: 10.1016/j.cld.2023.05.010. Epub 2023 Jul 1.
Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach.
Lanini S, Mammone A, Puro V, Girardi E, Bruzzi P, Ippolito G.
New Microbiol. 2014 Jul;37(3):263-76. Epub 2014 Jul 1.
Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines.
Chayama K, Hayes CN, Ohishi W, Kawakami Y.
J Gastroenterol. 2013 Jan;48(1):1-12. doi: 10.1007/s00535-012-0714-9. Epub 2012 Nov 28.
Management of side-effects.
Rosa I.
Clin Res Hepatol Gastroenterol. 2011 Dec;35 Suppl 2:S69-74. doi: 10.1016/S2210-7401(11)70011-0.
Efficacy and safety of simeprevir for chronic hepatitis virus C genotype 1 infection: A meta-analysis.
Qu Y, Li T, Wang L, Liu F, Ye Q.
Clin Res Hepatol Gastroenterol. 2016 Apr;40(2):203-12. doi: 10.1016/j.clinre.2015.06.021. Epub 2015 Jul 26.
Management of hepatitis C infection before and after liver transplantation.
Fagiuoli S, Ravasio R, Lucà MG, Baldan A, Pecere S, Vitale A, Pasulo L.
World J Gastroenterol. 2015 Apr 21;21(15):4447-56. doi: 10.3748/wjg.v21.i15.4447.
The kinetics of cancer cells and of HIV1: the problems of cell and virus rebounds and of latency.
Mathé G.
Biomed Pharmacother. 1998;52(10):413-20. doi: 10.1016/S0753-3322(99)80018-3.
Management of hepatitis C in HIV-infected persons.
Rodríguez-Rosado R, Pérez-Olmeda M, García-Samaniego J, Soriano V.
Antiviral Res. 2001 Nov;52(2):189-98. doi: 10.1016/s0166-3542(01)00184-x.
Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C.
Ogawa E, Furusyo N, Kajiwara E, Nomura H, Kawano A, Takahashi K, Dohmen K, Satoh T, Azuma K, Nakamuta M, Koyanagi T, Kotoh K, Shimoda S, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group.
J Gastroenterol Hepatol. 2015 Aug;30(8):1309-16. doi: 10.1111/jgh.12945.
